Abstract
Objectives
We investigated the association of genetic polymorphisms of NQO1, ALDH2, CYP2E1, and the combined genotype of these genes on lung cancer risk, and also evaluated the association after stratification by cumulative smoking amounts and alcohol drinking levels.
Methods
The case–control study was performed in 387 lung cancer patients and 387 age- and sex-matched cancer-free controls. Direct interview was conducted and the genotypes of NQO1, ALDH2, and CYP2E1 were investigated using PCR-RFLP or 5′-nuclease activity assay.
Results
The proportion of individuals with occupational history of mining was significantly higher in cases than in controls. The risk of lung cancer was significantly lower in light-drinkers (<108 g/week) than non-drinkers. The NQO1 Pro/Ser + Ser/Ser genotype showed an increased risk for lung cancer with a marginal significance (OR = 1.35, 95% CI = 0.99–1.86) compared with NQO1 Pro/Pro genotype. In heavy-smokers, the combination of NQO1 Pro/Ser + Ser/Ser and CYP2E1 c1/c1 genotype was associated with a significantly increased risk for lung cancer (OR = 2.25, 95% CI = 1.14–4.43) compared with those of NQO1 Pro/Pro and CYP2E1 c1/c2 + c2/c2 genotype. We found a significant interaction between alcohol drinking level and the CYP2E1 genotype (P = 0.0227).
Conclusions
Our result suggests that the risk of lung cancer is affected by smoking, alcohol drinking, and the genetic polymorphism of NQO1. In particular, genetic polymorphisms for NQO1, CYP2E1, and ALDH2 synergistically with cumulative smoking amounts and alcohol drinking levels interact in the carcinogenesis of lung cancer in Koreans.
Similar content being viewed by others
References
Kuper H, Adami HO, Boffetta P (2002) Tobacco use, cancer causation and public health impact. J Intern Med 251:455–466. doi:10.1046/j.1365-2796.2002.00993.x
Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R (1996) Mortality from smoking worldwide. Br Med Bull 52:12–21
Beckett WS (1993) Epidemiology and etiology of lung cancer. Clin Chest Med 14:1–15
Daly AK, Cholerton S, Armstrong M, Idle JR (1994) Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspec 102:55–61
Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D (2000) NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 129:77–97. doi:10.1016/S0009-2797(00)00199-X
Traver RD, Siegel D, Beall HD et al (1997) Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). Br J Cancer 75:69–75
Paul N, John DH (2004) Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutation Res 555:149–171. doi:10.1016/j.mrfmmm.2004.05.023
Gasdaska PY, Powis G, Hyman P, Fisher H (1993) Cigarette smoking is a determinant of DT-diphorase gene expression in human non-small cell lung carcinoma. Cancer Res 53:5458–5461
Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM (1995) Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 72:555–561
Enomoto N, Takase S, Yasuhara M, Takada A (1991) Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 15:141–144. doi:10.1111/j.1530-0277.1991.tb00532.x
Harada S (1989) Polymorphism of aldehyde dehydrogenase and its application to alcoholism. Electrophoresis 10:652–655. doi:10.1002/elps.1150100820
Koop DR (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6:724–730
Guengerich FP, Kim DH, Iwasaki M (1991) Role of cytochrome P450IIEI in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–179. doi:10.1021/tx00020a008
Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIEI gene. J Biochem (Tokyo) 110:559–565
Agarwal DP (2001) Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol 49:703–709. doi:10.1016/S0369-8114(01)00242-5
Gresner P, Gromadzinska J, Wasowicz W (2007) Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57:1–25. doi:10.1016/j.lungcan.2007.02.002
Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X (2005) An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res 582:71–78
Li LX, John CW, David PM et al (2001) The NAD(P)H:quinone Oxidoreductase 1 Gene Polymorphism and Lung Cancer: Differential Susceptibility Based on Smoking Behavior1. Cancer Epidemiol Biomarkers Prev 10:303–309
Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P (2001) Genetic polymorphisms of NAD(P)H quinine oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 33:133–141. doi:10.1016/S0169-5002(01)00182-9
Vineis P, Veglia F, Garte S et al (2007) Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol 18:1230–1242. doi:10.1093/annonc/mdm109
Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC (2001) Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer 34:177–183. doi:10.1016/S0169-5002(01)00243-4
Sunaga N, Kohno T, Yanagitani N et al (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11:730–738
Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M (2006) NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:979–987. doi:10.1158/1055-9965.EPI-05-0899
Yang M, Choi Y, Hwangbo B, Lee JS (2007) Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 57:135–142. doi:10.1016/j.lungcan.2007.03.005
Bock CH, Wenzlaff AS, Cote ML, Land SJ, Schwartz AG (2005) NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study. Carcinogenesis 26:381–386. doi:10.1093/carcin/bgh314
Wang SL, Lee H, Chen KW, Tsai KJ, Chen CY, Lin P (1999) Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer 26:27–34. doi:10.1016/S0169-5002(99)00070-7
Wang J, Deng Y, Li L et al (2003) Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci 94:448–452. doi:10.1111/j.1349-7006.2003.tb01463.x
Marchand LL, Wilkinson GR, Wilkens LR (1999) Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev 8:495–500
Kim RB, Yamazaki H, Chiba K et al (1996) In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 279:4–11
Tampo Y, Yonaha M (1996) Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes. Arch Biochem Biophys 334:163–174. doi:10.1006/abbi.1996.0442
Radjendirane V, Joseph P, Lee YH et al (1998) Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 273:7382–7389. doi:10.1074/jbc.273.13.7382
Chen W, Koenigs LL, Thompson SJ et al (1998) Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol 11:295–301. doi:10.1021/tx9701687
Gao Q, Doneanu CE, Shaffer SA, Adman ET, Goodlett DR, Nelson SD (2006) Identification of the interactions between cytochrome P450 2E1 and cytochrome b5 by mass spectrometry and site-directed mutagenesis. J Biol Chem 281:20404–20417. doi:10.1074/jbc.M601785200
Bandera EV, Freudenheim JL, Vena JE (2001) Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 10:813–821
Bandera EV, Freudenheim JL, Marshall JR et al (1997) Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Causes Control 8:819–820. doi:10.1023/A:1018456127018
Kono S, Ikeda M, Tokudome S, Nishizume M, Kuratsune M (1986) Alcohol and mortality: a cohort study of mele Japanses physicians. Int J Epidemiol 15:527–532. doi:10.1093/ije/15.4.527
Prescott E, Gronbaek M, Becker U, Sorensen TIA (1999) Alcohol intake and risk of lung cancer: influence of type of alcoholic beverage. Am J Epidemiol 149:463–470
De Stefani E, Correa P, Deneo-Pellegrini H (2002) Alcohol intake and risk of adenocarcinoma of the lung: a case-control study in Uruguay. Lung Cancer 38:9–14. doi:10.1016/S0169-5002(02)00153-8
Hori H, Kawano T, Endo M, Yuasa Y (1997) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol 25:568–575. doi:10.1097/00004836-199712000-00003
Yokoyama T, Yokoyama A, Kato H et al (2003) Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12:1227–1233
Yokoyama A, Muramatsu T, Ohmori T et al (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19:1383–1387. doi:10.1093/carcin/19.8.1383
Minegishi Y, Tsukino H, Muto M et al (2007) Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population. Cancer 110:353–362. doi:10.1002/cncr.22795
Yang M, Coles BF, Delongchamp R, Lang NP, Kadlubar FF (2002) Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue. Lung Cancer 38:15–21. doi:10.1016/S0169-5002(02)00150-2
Acknowledgments
This study was supported by the Eco-technopia 21 project of Ministry of Environment, South Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eom, SY., Zhang, Y.W., Kim, SH. et al. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control 20, 137–145 (2009). https://doi.org/10.1007/s10552-008-9225-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9225-7